Blockade of mIL‐6R alleviated lipopolysaccharide‐induced systemic inflammatory response syndrome by suppressing NF‐κB‐mediated Ccl2 expression and inflammasome activation

Jimin Dai(Air Force Engineering University), Zhi‐Nan Chen(National Medical Products Administration)
MedComm
May 6, 2022
Cited by 9


Related Papers